JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

ResMed Inc

Затворен

СекторЗдравеопазване

256.88 -0.38

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

254.5

Максимум

260.53

Ключови измерители

By Trading Economics

Приходи

-31M

349M

Продажби

-12M

1.3B

P/E

Средно за сектора

26.175

90.422

Дивидентна доходност

0.87

Марж на печалбата

26.096

Служители

10,600

EBITDA

-29M

503M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+15.75% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.87%

2.13%

Следващи печалби

22.04.2026 г.

Следваща дата на дивидент

19.03.2026 г.

Следваща дата на екс-дивидент

12.02.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-539M

37B

Предишно отваряне

257.26

Предишно затваряне

256.88

ResMed Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.01.2026 г., 22:31 ч. UTC

Печалби

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29.01.2026 г., 22:05 ч. UTC

Печалби

Stryker Logs Higher 4Q Profit On Sales Gains

29.01.2026 г., 21:54 ч. UTC

Печалби

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29.01.2026 г., 21:36 ч. UTC

Печалби

Visa 1Q Sales Climb on Strong Holiday Shopping

29.01.2026 г., 23:57 ч. UTC

Придобивния, сливания и поглъщания

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29.01.2026 г., 23:56 ч. UTC

Придобивния, сливания и поглъщания

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29.01.2026 г., 23:53 ч. UTC

Придобивния, сливания и поглъщания

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29.01.2026 г., 23:51 ч. UTC

Печалби

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29.01.2026 г., 23:49 ч. UTC

Пазарно говорене

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29.01.2026 г., 23:49 ч. UTC

Пазарно говорене

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29.01.2026 г., 23:35 ч. UTC

Печалби

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29.01.2026 г., 23:32 ч. UTC

Пазарно говорене

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29.01.2026 г., 23:32 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

29.01.2026 г., 23:15 ч. UTC

Пазарно говорене
Печалби

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29.01.2026 г., 22:27 ч. UTC

Печалби

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29.01.2026 г., 22:27 ч. UTC

Печалби

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29.01.2026 г., 22:12 ч. UTC

Печалби

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29.01.2026 г., 21:55 ч. UTC

Печалби

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29.01.2026 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Financial Services Roundup: Market Talk

29.01.2026 г., 21:50 ч. UTC

Печалби

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29.01.2026 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Health Care Roundup: Market Talk

29.01.2026 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

29.01.2026 г., 21:49 ч. UTC

Печалби

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29.01.2026 г., 21:46 ч. UTC

Печалби

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29.01.2026 г., 21:36 ч. UTC

Печалби

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29.01.2026 г., 21:32 ч. UTC

Печалби

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29.01.2026 г., 21:32 ч. UTC

Печалби

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29.01.2026 г., 21:30 ч. UTC

Печалби

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29.01.2026 г., 21:30 ч. UTC

Печалби

Apple 1Q Mac Rev $8.39B >AAPL

Сравнение с други в отрасъла

Ценова промяна

ResMed Inc Прогноза

Ценова цел

By TipRanks

15.75% нагоре

12-месечна прогноза

Среден 295.75 USD  15.75%

Висок 345 USD

Нисък 260 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за ResMed Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

12 ratings

7

Купи

5

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat